Block, Report, And Suspend Suspicious Shipments Act of 2021

Bill: 117-hr-768
Sponsor: full_name: Rep. McKinley, David B. [R-WV-1]
Introduced: 2021-02-03
Policy area: Crime and Law Enforcement
Subjects: Crime prevention

Criminal justice information and records

Drug trafficking and controlled substances

Law enforcement officers

Manufacturing

Retail and wholesale trades
Latest action: action_date: 2021-05-13
text: Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Summaries:
action_date: 2021-02-03
action_desc: Introduced in House
text: <p><b>Block, Report, And Suspend Suspicious Shipments Act of 2021</b></p> <p>This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances.</p> <p>In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), a manufacturer or distributor must also exercise due diligence and decline to fill the order.</p> <p>The DEA must issue regulations specifying the indicators that give rise to a suspicious order.</p>

action_date: 2021-05-12
action_desc: Passed House
text: <p><b>Block, Report, And Suspend Suspicious Shipments Act of 2021</b></p> <p>This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances.</p> <p>In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), a manufacturer or distributor must also exercise due diligence and decline to fill the order.</p> <p>The DEA must issue regulations specifying the indicators that give rise to a suspicious order.</p>

tv_txt: I 117th CONGRESS 1st Session H. R. 768 IN THE HOUSE OF REPRESENTATIVES February 3, 2021 Mr. McKinley (for himself and Mrs. Dingell ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committees on the Judiciary , and the Budget , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to clarify the process for registrants to exercise due diligence upon discovering a suspicious order, and for other purposes.

1. Short title This Act may be cited as the Block, Report, And Suspend Suspicious Shipments Act of 2021 . 2. Clarification of process for registrants to exercise due diligence upon discovering a suspicious order (a) In general Paragraph (3) of section 312(a) of the Controlled Substances Act ( 21 U.S.C. 832(a) ) is amended to read as follows: (3) upon discovering a suspicious order or series of orders— (A) exercise due diligence; (B) establish and maintain (for not less than a period to be determined by the Administrator of the Drug Enforcement Administration) a record of the due diligence that was performed; (C) decline to fill the order or series of orders if the due diligence fails to resolve all of the indicators that gave rise to the suspicion that filling the order or series of orders would cause a violation of this title by the registrant or the prospective purchaser; and (D) notify the Administrator of the Drug Enforcement Administration and the Special Agent in Charge of the Division Office of the Drug Enforcement Administration for the area in which the registrant is located or conducts business of— (i) each suspicious order or series of orders discovered by the registrant; and (ii) the indicators giving rise to the suspicion that filling the order or series of orders would cause a violation of this title by the registrant or the prospective purchaser. . (b) Regulations Not later than 1 year after the date of enactment of this Act, for purposes of section 312(a)(3) of the Controlled Substances Act, as amended by subsection (a), the Attorney General of the United States shall promulgate a final regulation specifying the indicators that give rise to a suspicion that filling an order or series of orders would cause a violation of the Controlled Substances Act ( 21 U.S.C. 801 et seq.) by a registrant or a prospective purchaser. (c) Applicability Section 312(a)(3) of the Controlled Substances Act, as amended by subsection (a), shall apply beginning on the day that is 1 year after the date of enactment of this Act. Until such day, section 312(a)(3) of the Controlled Substances Act shall apply as such section 312(a)(3) was in effect on the day before the date of enactment of this Act. 3. Determination of budgetary effects The budgetary effects of this Act, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled Budgetary Effects of PAYGO Legislation for this Act, submitted for printing in the Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior to the vote on passage.

tv_txt: I 117th CONGRESS 1st Session H. R. 768 IN THE HOUSE OF REPRESENTATIVES AN ACT To amend the Controlled Substances Act to clarify the process for registrants to exercise due diligence upon discovering a suspicious order, and for other purposes.

1. Short title This Act may be cited as the Block, Report, And Suspend Suspicious Shipments Act of 2021 . 2. Clarification of process for registrants to exercise due diligence upon discovering a suspicious order (a) In general Paragraph (3) of section 312(a) of the Controlled Substances Act ( 21 U.S.C. 832(a) ) is amended to read as follows: (3) upon discovering a suspicious order or series of orders— (A) exercise due diligence; (B) establish and maintain (for not less than a period to be determined by the Administrator of the Drug Enforcement Administration) a record of the due diligence that was performed; (C) decline to fill the order or series of orders if the due diligence fails to resolve all of the indicators that gave rise to the suspicion that filling the order or series of orders would cause a violation of this title by the registrant or the prospective purchaser; and (D) notify the Administrator of the Drug Enforcement Administration and the Special Agent in Charge of the Division Office of the Drug Enforcement Administration for the area in which the registrant is located or conducts business of— (i) each suspicious order or series of orders discovered by the registrant; and (ii) the indicators giving rise to the suspicion that filling the order or series of orders would cause a violation of this title by the registrant or the prospective purchaser. . (b) Regulations Not later than 1 year after the date of enactment of this Act, for purposes of section 312(a)(3) of the Controlled Substances Act, as amended by subsection (a), the Attorney General of the United States shall promulgate a final regulation specifying the indicators that give rise to a suspicion that filling an order or series of orders would cause a violation of the Controlled Substances Act ( 21 U.S.C. 801 et seq.) by a registrant or a prospective purchaser. (c) Applicability Section 312(a)(3) of the Controlled Substances Act, as amended by subsection (a), shall apply beginning on the day that is 1 year after the date of enactment of this Act. Until such day, section 312(a)(3) of the Controlled Substances Act shall apply as such section 312(a)(3) was in effect on the day before the date of enactment of this Act. 3. Determination of budgetary effects The budgetary effects of this Act, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled Budgetary Effects of PAYGO Legislation for this Act, submitted for printing in the Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior to the vote on passage.

Passed the House of Representatives May 12, 2021. Cheryl L. Johnson, Clerk.

tv_txt: IIB 117th CONGRESS 1st Session H. R. 768 IN THE SENATE OF THE UNITED STATES May 13, 2021 Received; read twice and referred to the Committee on the Judiciary AN ACT To amend the Controlled Substances Act to clarify the process for registrants to exercise due diligence upon discovering a suspicious order, and for other purposes.

1. Short title This Act may be cited as the Block, Report, And Suspend Suspicious Shipments Act of 2021 . 2. Clarification of process for registrants to exercise due diligence upon discovering a suspicious order (a) In general Paragraph (3) of section 312(a) of the Controlled Substances Act ( 21 U.S.C. 832(a) ) is amended to read as follows: (3) upon discovering a suspicious order or series of orders— (A) exercise due diligence; (B) establish and maintain (for not less than a period to be determined by the Administrator of the Drug Enforcement Administration) a record of the due diligence that was performed; (C) decline to fill the order or series of orders if the due diligence fails to resolve all of the indicators that gave rise to the suspicion that filling the order or series of orders would cause a violation of this title by the registrant or the prospective purchaser; and (D) notify the Administrator of the Drug Enforcement Administration and the Special Agent in Charge of the Division Office of the Drug Enforcement Administration for the area in which the registrant is located or conducts business of— (i) each suspicious order or series of orders discovered by the registrant; and (ii) the indicators giving rise to the suspicion that filling the order or series of orders would cause a violation of this title by the registrant or the prospective purchaser. . (b) Regulations Not later than 1 year after the date of enactment of this Act, for purposes of section 312(a)(3) of the Controlled Substances Act, as amended by subsection (a), the Attorney General of the United States shall promulgate a final regulation specifying the indicators that give rise to a suspicion that filling an order or series of orders would cause a violation of the Controlled Substances Act ( 21 U.S.C. 801 et seq.) by a registrant or a prospective purchaser. (c) Applicability Section 312(a)(3) of the Controlled Substances Act, as amended by subsection (a), shall apply beginning on the day that is 1 year after the date of enactment of this Act. Until such day, section 312(a)(3) of the Controlled Substances Act shall apply as such section 312(a)(3) was in effect on the day before the date of enactment of this Act. 3. Determination of budgetary effects The budgetary effects of this Act, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled Budgetary Effects of PAYGO Legislation for this Act, submitted for printing in the Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior to the vote on passage.

Passed the House of Representatives May 12, 2021. Cheryl L. Johnson, Clerk